Psoriasis arises from a collision of genetic susceptibility, immune dysfunction, and environmental triggers rather than any single cause. The disease runs in families and is strongly linked to specific immune-system genes, but those genes alone are not enough to produce plaques. Something in the environment, whether an infection, a medication, physical trauma, or psychological stress, typically flips the switch. Once activated, the immune system mounts an inflammatory assault on the skin that becomes self-sustaining, driven by a feedback loop between immune cells and the skin’s own structural cells. Understanding what launches that loop, what keeps it going, and why it recurs in the same spots has been a decades-long effort, and the picture that has emerged is considerably more layered than “overactive immune system.”
The Genetic Foundation
Psoriasis has one of the strongest genetic components of any common inflammatory disease. If one identical twin has it, the other has a roughly 70 percent chance of developing it too, a figure that drops sharply for non-identical twins and more distant relatives. The single most important genetic signal sits in a region of chromosome 6 called PSORS1, which encodes part of the immune system’s identification machinery. Within that region, a gene variant known as HLA-Cw6 (or HLA-C*06:02) stands out. It is repeatedly observed to affect disease course, age of onset, severity, and even treatment response, and it is especially associated with early-onset psoriasis that appears before age 40.1PubMed. HLA-Cw6 and psoriasis The variant has also been linked to psoriatic arthritis diagnosed at a younger age.2Dermatology and Venerology. Association of HLA-Cw6 with the Risk of Psoriasis and Arthropathic Psoriasis in the Ukrainian Population
But HLA-Cw6 is far from the whole story. Genome-wide studies have now identified more than 80 susceptibility regions. Many of them cluster around immune-signaling pathways, particularly the IL-23/IL-17 axis. Variants in the IL-12B gene and the IL-23 receptor gene have been confirmed as susceptibility factors for both plaque psoriasis and psoriatic arthritis, with odds ratios around 1.5 for the strongest associations.3PubMed. Genetic variants of the IL-23R pathway: association with psoriatic arthritis and psoriasis vulgaris, but no specific risk factor for arthritis Dozens of additional non-HLA genes have been implicated in psoriatic arthritis alone, spanning pathways that govern inflammation, cell signaling, and immune-cell activation.4International Journal of Rheumatic Diseases. Psoriatic arthritis: A systematic review of non‐HLA genetic studies and important signaling pathways No single gene causes psoriasis. The genetic architecture looks more like a collection of vulnerabilities, each nudging the immune system toward overreaction.
How the Immune System Turns on the Skin
The central engine of psoriasis is a signaling circuit called the IL-23/Th17 axis. In healthy skin, dendritic cells and keratinocytes produce modest amounts of the cytokine IL-23. In psoriatic skin, IL-23 production ramps up dramatically. IL-23 then stimulates a subset of T cells (Th17 cells) to survive, multiply, and pour out their own inflammatory molecules, especially IL-17A and IL-22.5PubMed Central. Pathophysiology of psoriasis: recent advances on IL-23 and Th17 cytokines IL-17A drives keratinocytes to proliferate at a furious rate and to recruit more immune cells, while IL-22 further thickens the skin. The result is the raised, scaly plaque that defines the disease.
This cytokine cascade is not just an academic detail. It is the reason modern biologic therapies work as well as they do. Drugs that block IL-23 or IL-17 intercept the loop at its most critical junctions, and clinical trials consistently show high rates of skin clearance when these cytokines are neutralized.6PubMed Central. The Role of Interleukin 23/17 Axis in Psoriasis Management: A Comprehensive Review of Clinical Trials The effectiveness of those drugs is itself strong evidence that the IL-23/Th17 axis sits at the core of disease maintenance.
On the keratinocyte side, the inflammatory signals do more than cause rapid turnover. In normal skin, a keratinocyte takes about a month to mature and shed. In a psoriatic plaque, that cycle compresses to just a few days. This runaway proliferation is driven in part by activation of a protein called STAT3 inside the keratinocytes, which acts as a growth accelerator. When pro-inflammatory signals like IL-1β and IL-6 are present, STAT3 keeps keratinocytes dividing and amplifies the inflammatory output of the skin itself.7The FASEB Journal. TCN2 Drives Psoriasis‐Like Inflammation and Keratinocyte Hyperproliferation, Correlating With IL‐1β and STAT3 Activation
The Autoimmune Spark
For years, researchers debated whether psoriasis should be classified as autoimmune or merely autoinflammatory. Recent work has shifted the balance toward autoimmunity by identifying specific self-molecules that the immune system appears to attack. A pivotal discovery involved the antimicrobial peptide LL37, which is overproduced in psoriatic skin. LL37 binds to fragments of the skin’s own DNA and packages them into particles that look, to certain immune cells, like a viral infection. These particles enter a type of dendritic cell and trigger the release of type I interferons, essentially tricking the innate immune system into launching an antiviral response against the body’s own material.8PubMed. Plasmacytoid dendritic cells sense self-DNA coupled with antimicrobial peptide This mechanism may be one of the earliest events in a new psoriatic lesion, breaking the immune system’s tolerance to self and kicking off the downstream inflammatory cascade.9PubMed. Antimicrobial peptides and self-DNA in autoimmune skin inflammation
On the adaptive immunity side, researchers have identified a melanocyte protein called ADAMTSL5 as a target of CD8+ T cells in psoriatic skin. These killer T cells, bearing a specific receptor, were found to directly attack melanocytes in the epidermis. When exposed to ADAMTSL5, CD8+ T cells from psoriasis patients (but not healthy controls) produced IL-17A, the same cytokine that drives plaque formation. This fits the HLA-C*06:02 genetic link neatly: the protein variant encoded by that gene is the one presenting the melanocyte antigen to the attacking T cells.10PubMed Central. Melanocyte antigen triggers autoimmunity in human psoriasis In other words, the strongest genetic risk factor for psoriasis may be doing its damage by displaying a self-protein to the immune system in a way that provokes attack.
Infections That Trigger Flares
The clearest environmental trigger with a known mechanism is streptococcal throat infection. Guttate psoriasis, the form that appears as a sudden eruption of small droplet-shaped lesions, frequently follows a strep throat episode. The connection is not coincidental. Streptococcal bacteria produce superantigens, toxins that activate large swaths of T cells at once. In patients with acute guttate psoriasis, skin lesions show a selective accumulation of T cells bearing a specific receptor type (Vβ2), and the streptococcal isolates from those patients secrete a superantigen known to expand precisely that T-cell population.11The Journal of Clinical Investigation. Evidence for a streptococcal superantigen-driven process in acute guttate psoriasis
Beyond the initial superantigen blast, a molecular mimicry hypothesis proposes that some of those activated T cells cross-react with a skin protein, possibly a form of keratin that resembles streptococcal M protein. Cytokines released during the superantigen response could increase expression of that skin protein, giving the cross-reactive T cells a sustained target even after the infection clears.12Immunology Today. Psoriasis — as an autoimmune disease caused by molecular mimicry This model helps explain why guttate psoriasis sometimes evolves into chronic plaque disease: the strep infection opens the door, and autoimmunity keeps it propped open.
Physical Trauma and the Koebner Phenomenon
People with psoriasis often notice new lesions appearing at sites of skin injury, whether from a cut, a burn, a tattoo, or even vigorous scratching. This is called the Koebner phenomenon, and it occurs in a substantial fraction of patients.13PubMed Central. Koebner phenomenon leading to the formation of new psoriatic lesions: evidences and mechanisms The triggers are not limited to cuts and scrapes. Chemical irritation, mechanical stress, surgical procedures, and even infections at the skin surface can set it off. One reason psoriatic plaques so commonly appear on the elbows and knees may relate to the constant low-level mechanical stress those areas experience. Keratinocytes can sense mechanical signals and respond through specific signaling pathways that promote inflammation, which in turn can induce the full psoriatic phenotype at the trauma site.14Experimental Dermatology. Characteristics and pathogenesis of Koebner phenomenon
Drugs That Can Start or Worsen Psoriasis
Several commonly prescribed medications are known to provoke psoriasis in people who have never had it or to worsen it in those who have. The strongest associations are with beta-blockers, lithium, antimalarial drugs like hydroxychloroquine, interferons, imiquimod, and terbinafine.15PubMed Central. Drug-induced psoriasis: clinical perspectives Beta-blockers, for instance, can cause entirely new psoriasis in patients who had no prior history of the disease.16PubMed Central. Mechanisms of Beta-Blocker Induced Psoriasis, and Psoriasis De Novo at the Cellular Level These drug-induced cases are a useful reminder that psoriasis is not a fixed genetic sentence. The underlying susceptibility may be present but silent indefinitely, only to be unmasked by a pharmacological nudge.
Stress and the Brain-Skin Connection
Ask people with psoriasis what triggers their flares, and stress will rank near the top. The mechanism involves more than a vague “mind-body connection.” Psychological stress dysregulates the hypothalamic-pituitary-adrenal (HPA) axis, altering cortisol signaling and systemic immune responses. In the skin itself, sensory nerve fibers undergo structural remodeling and release neuropeptides like Substance P and calcitonin gene-related peptide, which directly activate dendritic cells, promote T-cell proliferation, and stimulate keratinocytes to churn out inflammatory cytokines.17PubMed. Neurogenic Inflammation and Immune Dysregulation in Psoriasis: Mechanistic Pathways and Emerging Interventions The result is a neurogenic inflammatory loop: stress fires up the nerves, the nerves fire up the immune system, and the inflamed skin sends distress signals back to the brain. Skin cells themselves express a local version of the stress-hormone system, creating a miniature HPA axis right at the site of disease.18PubMed Central. The Brain-Skin Axis in Psoriasis-Psychological, Psychiatric, Hormonal, and Dermatological Aspects
The Microbiome on the Skin and in the Gut
Psoriatic skin does not host the same microbial community as healthy skin. Sequencing studies find that psoriatic lesions are enriched in Staphylococcus aureus and depleted of normally dominant commensal species like Staphylococcus epidermidis and Propionibacterium acnes. In mouse models, colonization with S. aureus drove strong Th17 polarization in the skin, while colonization with S. epidermidis did not.19PubMed Central. Alteration of the cutaneous microbiome in psoriasis and potential role in Th17 polarization Whether the altered microbiome is a cause or a consequence of psoriasis is still debated. It is likely both: genetic and environmental factors shift the microbial balance, and that shift feeds back into the immune dysfunction.20PubMed Central. The Skin Microbiome and Its Role in Psoriasis: A Review
The gut microbiome has emerged as a separate but related player. Several research groups have documented altered gut bacterial communities in psoriasis patients, including a relative decrease in bacteria that produce short-chain fatty acids, which are molecules that help maintain the intestinal barrier and promote regulatory immune cells. When that barrier weakens, microbial products that are normally confined to the intestine can leak into the bloodstream, triggering systemic inflammation.21PubMed. The gut microbiome in psoriasis and psoriatic arthritis This creates a feedback loop: gut dysbiosis promotes Th17 activation and suppresses regulatory T cells, which in turn worsens intestinal permeability, which lets more inflammatory material escape, which amplifies skin and systemic inflammation further.22PubMed Central. Psoriasis and gut microbes: research advances from mechanism to therapy The gut-skin axis is one of the more active areas of psoriasis research, though no gut-targeted therapy has yet become part of standard psoriasis treatment.
Blood Vessels Change Before the Plaques Show Up
One underappreciated element of psoriasis is the vascular component. Before visible epidermal thickening appears, the tiny capillaries in the upper dermis start to change. They become more tortuous, dilated, and permeable, and they elongate significantly.23PubMed Central. Angiogenesis drives psoriasis pathogenesis This new blood vessel growth (angiogenesis) is not just a bystander effect. The expanded, leaky vasculature nourishes the rapidly proliferating keratinocytes and gives inflammatory cells an easy route from the bloodstream into the skin.24International Journal of Dermatology and Venereology. Psoriasis Pathogenesis: What’s New in Angiogenesis and Angiopoietins The clinical sign of this is the Auspitz sign: when a psoriatic scale is peeled off, pinpoint bleeding appears from these superficial, distorted capillaries. Angiogenesis is now considered an active contributor to both the initiation and persistence of plaques.25PubMed Central. Expression of Angiogenic Factors in Psoriasis Vulgaris
Why Psoriasis Keeps Coming Back in the Same Spots
One of the most frustrating features of psoriasis is recurrence at previously affected sites. A plaque can clear completely with treatment, only to reappear in the exact same location months later. The explanation lies in tissue-resident memory T cells (Trm cells). After a flare resolves, CD8+ Trm cells persist in the epidermis and CD4+ Trm cells remain in the dermis of formerly affected skin. These cells are essentially sentinels left behind. When re-exposed to a trigger, local dendritic cells secrete IL-23, which activates the Trm cells, and the whole inflammatory cascade restarts without needing new immune cells to be recruited from the blood.26PubMed Central. Characteristics and sources of tissue-resident memory T cells in psoriasis relapse This explains why clinically “clear” skin is not immunologically normal: the memory of the disease is encoded in the tissue itself.27Immunology. The role and therapeutic strategies for tissue‐resident memory T cells, central memory T cells, and effector memory T cells in psoriasis Erasing these memory cells is now considered one of the key challenges for achieving true long-term remission rather than suppression.
Epigenetics and the Layer Between Genes and Environment
If genetics loads the gun and the environment pulls the trigger, epigenetics is the safety catch. Epigenetic mechanisms alter which genes are active or silent without changing the DNA sequence itself. In psoriasis, three types of epigenetic change have been documented: shifts in DNA methylation patterns, modifications to histone proteins that change how tightly DNA is packed, and non-coding RNAs (including microRNAs) that dial gene activity up or down after the gene has been read.28PubMed Central. The Role of Epigenetic Factors in Psoriasis These changes may help explain why psoriasis can appear or worsen in response to environmental exposures, and why disease severity can fluctuate over a lifetime even though the underlying DNA sequence stays the same. They also open up the possibility that some environmental triggers leave lasting marks on gene regulation, contributing to chronicity.
Hormones and Sex-Based Differences
Psoriasis affects men and women at roughly similar rates, but the disease does not behave identically across sexes. In women, fluctuations in estrogen levels correlate with changes in disease severity. Low estrogen periods, such as just before menstruation and after menopause, tend to coincide with worsening symptoms. Pregnancy, when estrogen is high, often brings improvement, while the postpartum estrogen crash frequently triggers severe flares. Menopause, with its sustained drop in estrogen, is associated with both increased severity and more frequent flares.29Journal of Clinical Medicine. How Hormonal Balance Changes Lives in Women with Psoriasis These patterns point to estrogen as an immunomodulator that, when present in sufficient amounts, restrains the inflammatory pathways driving psoriasis. The implication for clinical management is that hormonal transitions should be treated as risk windows, and women approaching menopause or the postpartum period should anticipate the possibility of increased disease activity.
From Skin Disease to Psoriatic Arthritis
Roughly a quarter to a third of people with psoriasis eventually develop psoriatic arthritis, and the transition is not random. Research examining immune cells in the blood has found that the shift from skin-only disease to joint involvement is accompanied by distinct changes in circulating T-cell populations. Specifically, a subtype of cytotoxic T cells that produce IL-17 (called Tc17 cells) appears to be the strongest distinguishing feature between patients with psoriasis alone and those progressing toward arthritis.30Arthritis & Rheumatology. Transition From Psoriasis to Psoriatic Arthritis is Characterized by Distinct Alterations in Peripheral Blood Tc17, Th17, and CD4+ Effector Memory Cells This suggests the transition involves a measurable escalation in the same IL-17-driven immunity that fuels the skin disease, and it opens the door to screening blood markers that might predict who is at highest risk of joint involvement. Metabolic factors may add fuel: adipose tissue is now recognized as an active endocrine organ that produces inflammatory mediators called adipokines, which could contribute to systemic progression in patients who are overweight.31PubMed Central. The Role of Adipokines in the Pathogenesis of Psoriasis
Why Psoriasis Genes Survived Natural Selection
A disease this common and this heritable raises an obvious evolutionary question: why hasn’t natural selection weeded out the responsible gene variants? One answer is that some of those variants confer advantages against infectious diseases. A well-known psoriasis-associated deletion in the late cornified envelope gene cluster (LCE3B/LCE3C) has been maintained in human populations under balancing selection since before the divergence of modern humans and Denisovans. The hypothesis is that this deletion bolsters skin barrier immunity against pathogens, and the trade-off for that benefit is increased susceptibility to autoimmunity.32PubMed Central. The psoriasis-associated deletion of late cornified envelope genes LCE3B and LCE3C has been maintained under balancing selection since Human Denisovan divergence A separate and striking observation is that psoriasis and leprosy are almost mutually exclusive, both clinically and genetically. The HLA patterns that predispose to one tend to protect against the other. This has led to the proposal that resisting leprosy may have been the evolutionary advantage that favored the expansion of psoriasis-associated genotypes, particularly in the ancestors of modern Europeans.33PubMed. Leprosy and the natural selection for psoriasis The genes that make psoriasis possible, in other words, may be the price of an immune system tuned for aggressive pathogen defense.